➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKesson
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MINOXIDIL (FOR WOMEN)

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

505(b)(2) Clinical Trials for Minoxidil (for Women)

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT01325337 ↗ Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia Completed Allergan Phase 2 2011-06-01 This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic alopecia. All treatments will be provided in a double-blinded fashion except for minoxidil 5% solution which will be provided open-label.
OTC NCT01325350 ↗ Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss Completed Allergan Phase 2 2011-06-01 This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 2% solution in women with female pattern hair loss. All treatments will be provided in a double-blinded fashion except for minoxidil 2% solution which will be provided open-label.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Minoxidil (for Women)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00007592 ↗ Hypertension Screening and Treatment Program Completed VA Office of Research and Development N/A 1989-06-01 Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.
NCT00151515 ↗ A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss Completed Johnson & Johnson Consumer and Personal Products Worldwide Phase 3 2003-10-01 The primary purpose of the study is to evaluate the efficacy of a topical 5% minoxidil formulation in males for the treatment of pattern hair loss. The secondary purpose is to evaluate the safety of a topical 5% minoxidil formulation in males when used twice daily for the treatment of pattern hair loss and to obtain the safety data on the investigational product when used twice daily for up to one year.
NCT00175617 ↗ Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss Unknown status University of British Columbia Phase 2 2005-09-01 This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Minoxidil (for Women)

Condition Name

Condition Name for Minoxidil (for Women)
Intervention Trials
Androgenetic Alopecia 17
Alopecia 6
Female Pattern Hair Loss 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Minoxidil (for Women)
Intervention Trials
Alopecia 39
Alopecia Areata 37
Hypertension 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Minoxidil (for Women)

Trials by Country

Trials by Country for Minoxidil (for Women)
Location Trials
United States 54
Germany 7
Thailand 7
Egypt 5
France 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Minoxidil (for Women)
Location Trials
Texas 6
Oregon 4
Minnesota 4
Ohio 4
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Minoxidil (for Women)

Clinical Trial Phase

Clinical Trial Phase for Minoxidil (for Women)
Clinical Trial Phase Trials
Phase 4 14
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Minoxidil (for Women)
Clinical Trial Phase Trials
Completed 22
Not yet recruiting 9
Recruiting 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Minoxidil (for Women)

Sponsor Name

Sponsor Name for Minoxidil (for Women)
Sponsor Trials
Mae Fah Luang University Hospital 5
Assiut University 3
Allergan 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Minoxidil (for Women)
Sponsor Trials
Other 43
Industry 17
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Express Scripts
Boehringer Ingelheim
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.